Altogether, these data suggest that CD20 normally does not form hetero-oligomers with other MS4A proteins and that there are unlikely to be other MS4A proteins in CLL that might provide useful alternate therapeutic targets. Here, MS4A1 is linked to B-cell chronic lymphocytic leukemia.